modular phase i/ii clinical trial evaluating the selective met-kinase inhibitor omo-1 in patient...
Published 5 years ago • 134 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
4:48
findings of a phase i/ii study of nivolumab in patients with virus-associated tumours
-
4:12
[50] phase i and pharmacologic study of osi-774, an egfr tki, for advanced solid malignancies
-
3:21
overview of a phase i clinical trial using bgb-3111 for the treatment of relapsed cll
-
6:45
anti-pd1 or tyrosine kinase inhibitors?
-
30:30
response prediction for a multi tyrosine kinase inhibitor
-
2:15
phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
-
33:30
bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: context and impact of new data
-
5:41
tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia
-
2:08
for physicians: vegf tyrosine kinase inhibitor treatment risks | dana-farber cancer institute
-
18:48
olverembatinib after failure of tyrosine kinase inhibitors, including ponatinib or asciminib
-
2:28
clinical trials of neoadjuvant targeted therapy in resectable nsclc
-
3:57
novel kinase inhibitor promising in nsclc
-
2:42
cediranib and lenalidomide in iodine 131-refractory differentiated thyroid cancer
-
20:28
uncovering a small molecule binding site for modulation of hcn1 channels - elizabeth kim
-
5:43
are there any clinical trials for aurora kinase inhibitors in cd56 positive mesothelioma?
-
6:46
case 1: clinical trials in early-stage her2 breast cancer
-
4:22
selective kinase inhibitors of the tyk2 protein, tyra jones
-
19:09
harnessing the kinome: multi-kinase inhibitors for the management of hepatocellular carcinoma